Inventor

OSTERHAUS ALBERTUS D M E

NL9 patents

⚠️ This page may combine multiple inventors who share the name “OSTERHAUS ALBERTUS D M E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV ERASMUS MEDICAL CT

2 patents

US9376726B2Jun 28, 2016

Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences

UNIV ERASMUS MEDICAL CT24 citations96

US9334543B2May 10, 2016

Virus causing respiratory tract illness in susceptible mammals

UNIV ERASMUS MEDICAL CT9 citations91

UNIV ERASMUS

2 patents

US6319666B1Nov 20, 2001

Induction of REV and TAT specific cytotoxic T-cells for prevention and treatment of human immunodeficiency virus (HIV) infection

UNIV ERASMUS21 citations89

US5942401AAug 24, 1999

Method of determining favorable prognosis against progressing from an asymptomatic condition to AIDS in an human immunodeficiency virus (HIV) positive subject

UNIV ERASMUS8 citations70

ERASUMS UNIVERSITY ROTTERDAM

1 patent

US6024965AFeb 15, 2000

Induction of REV and TAT specific cytotoxic T-cells for prevention and treatment of human immunodeficiency virus (HIV) infection

ERASUMS UNIVERSITY ROTTERDAM21 citations86

OSTERHAUS ALBERTUS D M E

1 patent

US10485863B2Nov 26, 2019

Influenza vaccine

OSTERHAUS ALBERTUS D M E2 citations65

UNIV ERASMUS MED CT ROTTERDAM

1 patent

US11162148B2Nov 2, 2021

Virus causing respiratory tract illness in susceptible mammals

UNIV ERASMUS MED CT ROTTERDAM0 citations62

HORZINEK MARIAN C

1 patent

US4293653AOct 6, 1981

Method for propagating feline infectious peritonitis virus

HORZINEK MARIAN C8 citations60

Novavax AB

1 patent

US10736958B2Aug 11, 2020

Influenza vaccine

Novavax AB0 citations48